GlassScriptPhysician profile
Valerie Halpin
NPI 1750307989
$18,287.92
in general payments reported to CMS, 2019-2025
12 companies · $743 in 2025
The $743 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,499 · 2020: $162 · 2021: $4,732 · 2022: $1,531 · 2023: $1,877 · 2024: $744 · 2025: $743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,165 · Travel and Lodging: $1,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,164.61 |
| Travel and Lodging | $1,199.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,308.70 | 2021-2025 | Endoflip, Signia, Endo Stitch |
| Covidien LP | $5,004.75 | 2019 | |
| Intuitive Surgical, INC. | $3,548.15 | 2019-2025 | Da Vinci Surgical System |
| Ethicon US, LLC | $1,889.07 | 2019-2025 | Echelon; Endopath, Echelon Flex, Echelon Circular |
| Medical Device Business Services, INC. | $1,542.02 | 2019-2023 | |
| Enterra Medical, INC. | $307.54 | 2022-2023 | |
| Boston Scientific Corporation | $212.59 | 2019-2020 | |
| Kerecis Limited | $138.97 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Mauna Kea Technologies, INC. | $120.65 | 2025 | |
| Cook Medical LLC | $108.39 | 2025 | Hemospray |
| W. L. Gore & Associates, INC. | $86.09 | 2019 | |
| Virtual Incision Corporation | $21.00 | 2024 | Mira |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Valerie Halpin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.